Annual EBITDA:
$176.36M+$13.46M(+8.26%)Summary
- As of today, PCRX annual EBITDA is $176.36 million, with the most recent change of +$13.46 million (+8.26%) on December 31, 2024.
- During the last 3 years, PCRX annual EBITDA has risen by +$14.98 million (+9.28%).
- PCRX annual EBITDA is now at all-time high.
Performance
PCRX EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBITDA:
$29.24M-$4.37M(-13.00%)Summary
- As of today, PCRX quarterly EBITDA is $29.24 million, with the most recent change of -$4.37 million (-13.00%) on June 30, 2025.
- Over the past year, PCRX quarterly EBITDA has dropped by -$29.33 million (-50.07%).
- PCRX quarterly EBITDA is now -51.33% below its all-time high of $60.08 million, reached on June 30, 2023.
Performance
PCRX Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$1.30M-$29.33M(-104.64%)Summary
- As of today, PCRX TTM EBITDA is -$1.30 million, with the most recent change of -$29.33 million (-104.64%) on June 30, 2025.
- Over the past year, PCRX TTM EBITDA has dropped by -$187.29 million (-100.70%).
- PCRX TTM EBITDA is now -100.69% below its all-time high of $187.51 million, reached on March 31, 2024.
Performance
PCRX TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
PCRX EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +8.3% | -50.1% | -100.7% |
| 3Y3 Years | +9.3% | -42.5% | -100.9% |
| 5Y5 Years | +219.0% | +987.0% | -102.8% |
PCRX EBITDA Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +9.3% | -51.3% | +125.5% | -100.7% | at low |
| 5Y | 5-Year | at high | +219.0% | -51.3% | +125.5% | -100.7% | at low |
| All-Time | All-Time | at high | +470.9% | -51.3% | +125.5% | -100.7% | +97.8% |
PCRX EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $29.24M(-13.0%) | -$1.30M(-104.6%) |
| Mar 2025 | - | $33.61M(-33.6%) | $28.03M(-3.8%) |
| Dec 2024 | $176.36M(+8.3%) | $50.60M(+144.1%) | $29.12M(-12.9%) |
| Sep 2024 | - | -$114.75M(-295.9%) | $33.42M(-82.0%) |
| Jun 2024 | - | $58.57M(+68.8%) | $185.99M(-0.8%) |
| Mar 2024 | - | $34.70M(-36.8%) | $187.51M(+21.3%) |
| Dec 2023 | $162.90M(+0.3%) | $54.91M(+45.2%) | $154.59M(+27.1%) |
| Sep 2023 | - | $37.81M(-37.1%) | $121.61M(+5.7%) |
| Jun 2023 | - | $60.08M(+3275.4%) | $115.02M(+8.7%) |
| Mar 2023 | - | $1.78M(-91.9%) | $105.77M(-24.7%) |
| Dec 2022 | $162.43M(+0.6%) | $21.93M(-29.7%) | $140.38M(+4.0%) |
| Sep 2022 | - | $31.22M(-38.6%) | $134.96M(-3.9%) |
| Jun 2022 | - | $50.83M(+39.7%) | $140.37M(+11.0%) |
| Mar 2022 | - | $36.39M(+120.3%) | $126.45M(+11.0%) |
| Dec 2021 | $161.38M(+126.0%) | $16.52M(-54.9%) | $113.95M(-6.3%) |
| Sep 2021 | - | $36.63M(-0.8%) | $121.61M(+18.4%) |
| Jun 2021 | - | $36.91M(+54.5%) | $102.67M(+50.0%) |
| Mar 2021 | - | $23.89M(-1.2%) | $68.45M(+7.8%) |
| Dec 2020 | $71.42M(+29.2%) | $24.17M(+36.6%) | $63.51M(+36.7%) |
| Sep 2020 | - | $17.69M(+557.6%) | $46.45M(+36.4%) |
| Jun 2020 | - | $2.69M(-85.8%) | $34.06M(-21.2%) |
| Mar 2020 | - | $18.96M(+166.6%) | $43.23M(+40.6%) |
| Dec 2019 | $55.29M(+46.5%) | $7.11M(+34.2%) | $30.75M(-25.6%) |
| Sep 2019 | - | $5.30M(-55.3%) | $41.35M(-6.2%) |
| Jun 2019 | - | $11.86M(+83.2%) | $44.08M(+3.3%) |
| Mar 2019 | - | $6.48M(-63.4%) | $42.66M(+29.1%) |
| Dec 2018 | $37.74M(+4268.5%) | $17.71M(+120.5%) | $33.06M(+16.6%) |
| Sep 2018 | - | $8.03M(-23.0%) | $28.34M(+35.9%) |
| Jun 2018 | - | $10.44M(+433.7%) | $20.85M(+2861.6%) |
| Mar 2018 | - | -$3.13M(-124.1%) | -$755.00K(+93.7%) |
| Dec 2017 | $864.00K | $13.00M(+2293.6%) | -$11.97M(+50.1%) |
| Sep 2017 | - | $543.00K(+104.9%) | -$24.00M(+42.8%) |
| Jun 2017 | - | -$11.17M(+22.1%) | -$41.94M(-23.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2017 | - | -$14.34M(-1575.7%) | -$33.88M(-83.4%) |
| Dec 2016 | -$12.01M(-157.4%) | $972.00K(+105.6%) | -$18.48M(-7.4%) |
| Sep 2016 | - | -$17.40M(-460.6%) | -$17.21M(-311.2%) |
| Jun 2016 | - | -$3.10M(-393.4%) | $8.14M(-48.7%) |
| Mar 2016 | - | $1.06M(-52.8%) | $15.87M(-23.4%) |
| Dec 2015 | $20.93M(+329.8%) | $2.24M(-71.8%) | $20.70M(-28.7%) |
| Sep 2015 | - | $7.95M(+72.2%) | $29.05M(+29.9%) |
| Jun 2015 | - | $4.62M(-21.7%) | $22.37M(+31.8%) |
| Mar 2015 | - | $5.90M(-44.3%) | $16.97M(+294.1%) |
| Dec 2014 | $4.87M(+110.2%) | $10.58M(+733.3%) | $4.31M(+128.3%) |
| Sep 2014 | - | $1.27M(+262.8%) | -$15.20M(+45.8%) |
| Jun 2014 | - | -$780.00K(+88.5%) | -$28.03M(+26.4%) |
| Mar 2014 | - | -$6.77M(+24.1%) | -$38.08M(+26.7%) |
| Dec 2013 | -$47.54M(-8.9%) | -$8.92M(+22.8%) | -$51.94M(+9.8%) |
| Sep 2013 | - | -$11.56M(-6.7%) | -$57.58M(+3.9%) |
| Jun 2013 | - | -$10.83M(+47.5%) | -$59.89M(-8.0%) |
| Mar 2013 | - | -$20.63M(-41.7%) | -$55.46M(-23.7%) |
| Dec 2012 | -$43.65M(-37.4%) | -$14.56M(-4.9%) | -$44.83M(-3.9%) |
| Sep 2012 | - | -$13.87M(-116.9%) | -$43.15M(-16.7%) |
| Jun 2012 | - | -$6.40M(+36.0%) | -$36.98M(+1.8%) |
| Mar 2012 | - | -$10.00M(+22.4%) | -$37.66M(-11.4%) |
| Dec 2011 | -$31.77M(-73.6%) | -$12.88M(-67.2%) | -$33.79M(-32.2%) |
| Sep 2011 | - | -$7.70M(-8.9%) | -$25.57M(-8.0%) |
| Jun 2011 | - | -$7.08M(-15.4%) | -$23.67M(-11.7%) |
| Mar 2011 | - | -$6.13M(-31.7%) | -$21.19M(-13.6%) |
| Dec 2010 | -$18.30M(+25.0%) | -$4.66M(+19.7%) | -$18.66M(+9.0%) |
| Sep 2010 | - | -$5.80M(-26.3%) | -$20.50M(-3.2%) |
| Jun 2010 | - | -$4.59M(-27.5%) | -$19.86M(-30.1%) |
| Mar 2010 | - | -$3.60M(+44.6%) | -$15.26M(-30.9%) |
| Dec 2009 | -$24.40M(+40.7%) | -$6.50M(-26.1%) | -$11.66M(-126.1%) |
| Sep 2009 | - | -$5.16M | -$5.16M |
| Dec 2008 | -$41.14M(-80.2%) | - | - |
| Dec 2007 | -$22.83M | - | - |
FAQ
- What is Pacira BioSciences, Inc. annual EBITDA?
- What is the all-time high annual EBITDA for Pacira BioSciences, Inc.?
- What is Pacira BioSciences, Inc. annual EBITDA year-on-year change?
- What is Pacira BioSciences, Inc. quarterly EBITDA?
- What is the all-time high quarterly EBITDA for Pacira BioSciences, Inc.?
- What is Pacira BioSciences, Inc. quarterly EBITDA year-on-year change?
- What is Pacira BioSciences, Inc. TTM EBITDA?
- What is the all-time high TTM EBITDA for Pacira BioSciences, Inc.?
- What is Pacira BioSciences, Inc. TTM EBITDA year-on-year change?
What is Pacira BioSciences, Inc. annual EBITDA?
The current annual EBITDA of PCRX is $176.36M
What is the all-time high annual EBITDA for Pacira BioSciences, Inc.?
Pacira BioSciences, Inc. all-time high annual EBITDA is $176.36M
What is Pacira BioSciences, Inc. annual EBITDA year-on-year change?
Over the past year, PCRX annual EBITDA has changed by +$13.46M (+8.26%)
What is Pacira BioSciences, Inc. quarterly EBITDA?
The current quarterly EBITDA of PCRX is $29.24M
What is the all-time high quarterly EBITDA for Pacira BioSciences, Inc.?
Pacira BioSciences, Inc. all-time high quarterly EBITDA is $60.08M
What is Pacira BioSciences, Inc. quarterly EBITDA year-on-year change?
Over the past year, PCRX quarterly EBITDA has changed by -$29.33M (-50.07%)
What is Pacira BioSciences, Inc. TTM EBITDA?
The current TTM EBITDA of PCRX is -$1.30M
What is the all-time high TTM EBITDA for Pacira BioSciences, Inc.?
Pacira BioSciences, Inc. all-time high TTM EBITDA is $187.51M
What is Pacira BioSciences, Inc. TTM EBITDA year-on-year change?
Over the past year, PCRX TTM EBITDA has changed by -$187.29M (-100.70%)